Company Overview of Primus Therapeutics, Inc.
Key Executives for Primus Therapeutics, Inc.
|Dennis M. O'Donnell R.Ph., MBA||3 Relationships||Co-Founder, Chief Executive Officer, President and Director||61|
|Mark I. Massad CPA||No Relationships||Chief Financial Officer and Principal Accounting Officer||--|
Primus Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Joseph A. Falsetti||10 Relationships||Primus Therapeutics, Inc.||60|
|Dennis M. O'Donnell R.Ph., MBA||3 Relationships||Primus Therapeutics, Inc.||61|
|Robert Joseph Hariri M.D., Ph.D.||117 Relationships||MYOS RENS Technology Inc.||58|
|Andrew M. Sadosky||3 Relationships||Primus Therapeutics, Inc.||63|
Primus Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Andrew M. Sadosky||3 Relationships||2 Executives|
|Compensation Committee M.D., Ph.D.||Robert Joseph Hariri||117 Relationships||2 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$215.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.